Audrey Sternberg
Articles
Effective Frontline RCC Treatment Navigation Is Tied to Risk Stratification
March 18, 2022
Article
Patients with metastatic renal cell carcinoma have multiple effective frontline treatment options.
Palbociclib Shows Clinical Benefit in Black and Hispanic Patients with HR+ Breast Cancer
December 09, 2021
Article
Findings from a pooled efficacy and safety analysis support the use of palbociclib plus endocrine therapy in patients who are Black or Hispanic with hormone receptor–positive, HER2-negative breast cancer.
Patients Report Improved Outcomes Following Mobocertinib Treatment for NSCLC Subtype
September 09, 2021
Article
Selectively targeting the EGFR exon insertion mutations was associated with improved outcomes in patients with previously treated non-small cell lung cancer.
Cancer Center Seeks to Improve Patient Experience, Satisfaction Through Communication Education With Staff
April 20, 2021
Article
A poster presentation from the Oncology Nursing Society’s 46th Annual Congress describes a single-center clinician education program aimed at improving patient satisfaction.
COVID-19 Leaves Its Mark on Cancer Care
September 14, 2020
Article
As the impact of the coronavirus disease 2019 (COVID-19) pandemic lingers into the later part of 2020, consideration is needed regarding the lasting effects on patients with cancer who may have experienced delayed care or diagnosis.
Accelerated Chemo Regimen Extends OS in Neoadjuvant Bladder Cancer Treatment
January 29, 2019
Article
Neoadjuvant chemotherapy with dose-dense MVAC extends overall survival compared with other chemo regimens in bladder cancer treated with cystectomy.
Tumor Treating Fields May Address Unmet Need in Ovarian Cancer Treatment
August 17, 2018
Article
The addition of tumor treating fields (TTF), an antimitotic therapy that delivers continuous low-intensity electrical fields to the tumor region, to weekly paclitaxel (Taxol) appeared safe in the treatment of patients with platinum-resistant ovarian cancer.
Managing Adverse Events in Patients Taking Abemaciclib
August 10, 2018
Article
As abemaciclib (Verzenio) has emerged as a promising agent for patients with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer, the oncology nurse is now a key factor for these patients, according to Paula Fulgham, RN, OCN.
How to Identify and Respond to Immunotherapy-Related Adverse Events
August 10, 2018
Article
The favored use of immune checkpoint inhibitors in oncology has led to an increase in immune-related adverse events (IRAEs), which if not managed properly, can be life-threatening.